AB017. NFκB1 regulates FDX1 to facilitate elesclomol-induced cuproptosis against glioblastoma

Authors

Institutions

Publication Details

Journal
Chinese Clinical Oncology
Published
2024-08-01
DOI
https://doi.org/10.21037/cco-24-ab017
Citations
2
Primary Topic
NF-κB Signaling Pathways
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AB017. NFκB1 regulates FDX1 to facilitate elesclomol-induced cuproptosis against glioblastoma

Anyi Wu, Jun Dong, Zhipeng Xu, Nanheng Yin
2 citations
Chinese Clinical Oncology
NF-κB Signaling Pathways
0.57
article

AB017. NFκB1 regulates FDX1 to facilitate elesclomol-induced cuproptosis against glioblastoma

Anyi Wu, Jun Dong, Zhipeng Xu, Nanheng Yin
article en
2 citations

Abstract

No abstract available for this paper.
Chinese Clinical OncologyVol. 13(Suppl 1)
Soochow University (CN), Second Affiliated Hospital of Soochow University (CN)
Openalex Percentile: Top 32%
NF-κB Signaling Pathways
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

AB017. NFκB1 regulates FDX1 to facilitate elesclomol-induced cuproptosis against glioblastoma — Anyi Wu, Jun Dong, et al. · Chinese Clinical Oncology (2024) | TGRS Research Map | TGRS